PPD has acquired RCT Logic’s exclusive license from Massachusetts General Hospital (MGH) for the portfolio of patents related to its sequential parallel comparison design (SPCD), an alternative method for conducting clinical trials designed to decrease the impact of  placebo effect on trial outcomes. PPD will brand this methodology as Trimentum, which has been shown to be effective in studying major depressive disorder (MDD), but is applicable to clinical trials in other disease areas.   The SPC...